These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37317353)

  • 1. Receiving Industry Payments is Associated with Prescribing Habits of Tadalafil.
    Chua KJ; Li G; Stahl PJ; Hyams ES
    Urol Pract; 2019 Sep; 6(5):282-288. PubMed ID: 37317353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial Relationships between Urologists and Industry: An Analysis of Open Payments Data.
    Maruf M; Sidana A; Fleischman W; Brancato SJ; Purnell S; Agrawal S; Agarwal PK
    Urol Pract; 2018 May; 5(3):180-186. PubMed ID: 37300223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotional Payments Made to Urologists by the Pharmaceutical Industry and Prescribing Patterns for Targeted Therapies.
    Hollenbeck BK; Oerline M; Kaufman SR; Caram MEV; Dusetzina SB; Ryan AM; Shahinian VB
    Urology; 2021 Feb; 148():134-140. PubMed ID: 33075381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide.
    Bandari J; Ayyash OM; Turner RM; Jacobs BL; Davies BJ
    Cancer; 2017 Nov; 123(22):4356-4362. PubMed ID: 28749536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
    Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industry Payments to Urologists in 2014: an Analysis of the Open Payments Program.
    Modi PK; Farber NJ; Zavaski ME; Jang TL; Singer EA; Chang SL
    Urol Pract; 2017 Jul; 4(4):342-347. PubMed ID: 28775998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotional Payments to Medical Oncologists and Urologists and Prescriptions for Abiraterone and Enzalutamide.
    Lai LY; Oerline MK; Kaufman SR; Herrel LA; Skolarus TA; Dusetzina SB; Ellimoottil C; Shahinian VB; Hollenbeck BK; Caram MEV
    Urology; 2022 Mar; 161():50-58. PubMed ID: 34861316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry Payments to Urologists and Urologic Advanced Practice Providers in 2021.
    Reed S; Singh A; Hyman MJ; Meltzer DO; Sales AE; Skolarus TA; Modi PK
    Urology; 2023 Oct; 180():121-129. PubMed ID: 37517679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship of Industry Payments to Prescribing Behavior: A Study of Degarelix and Denosumab.
    Bandari J; Turner RM; Jacobs BL; Canes D; Moinzadeh A; Davies BJ
    Urol Pract; 2017 Jan; 4(1):14-20. PubMed ID: 28149927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association between Industry Payments and Brand-Name Prescriptions in Otolaryngologists.
    Morse E; Hanna J; Mehra S
    Otolaryngol Head Neck Surg; 2019 Oct; 161(4):605-612. PubMed ID: 31547772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender Disparities in Industry Payments to Urologists.
    Velez D; Mehta A; Rotker K; Thavaseelan S
    Urology; 2021 Apr; 150():59-64. PubMed ID: 32569655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs.
    Perlis RH; Perlis CS
    PLoS One; 2016; 11(5):e0155474. PubMed ID: 27183221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Rich Get Richer: The Matthew Effect in Open Payments.
    Tomblin C; Wang R; McMullin J; Chen H; Gillis A
    J Surg Res; 2024 Jan; 293():693-700. PubMed ID: 37839101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association of Industry Payments to Physicians with Prescription of Brand-Name Intranasal Corticosteroids.
    Morse E; Fujiwara RJT; Mehra S
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):442-448. PubMed ID: 29865931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industry Payments to Physicians and Prescribing Branded Memantine and Donepezil Combination.
    Marcum ZA; Chang CY; Barthold D; Holmes HM; Lo-Ciganic WH
    Neurol Clin Pract; 2021 Jun; 11(3):181-187. PubMed ID: 34484885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology.
    Duarte-García A; Crowson CS; McCoy RG; Herrin J; Lam V; Putman MS; Ross JS; Matteson EL; Shah ND
    Mayo Clin Proc; 2022 Feb; 97(2):250-260. PubMed ID: 35120693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.
    Wood SF; Podrasky J; McMonagle MA; Raveendran J; Bysshe T; Hogenmiller A; Fugh-Berman A
    PLoS One; 2017; 12(10):e0186060. PubMed ID: 29069085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.
    Fleischman W; Agrawal S; King M; Venkatesh AK; Krumholz HM; McKee D; Brown D; Ross JS
    BMJ; 2016 Aug; 354():i4189. PubMed ID: 27540015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.